Clinical and Laboratory Profile of Myasthenia Gravis in Children At Sohag University Hospitals

Launched by SOHAG UNIVERSITY · Jan 13, 2025

Keywords

ClinConnect Summary

This clinical trial is studying Myasthenia Gravis, a condition that affects muscle strength, in children at Sohag University Hospitals. The researchers will look at both clinical (how the disease presents in patients) and laboratory (test results) data to better understand how this condition affects young patients. The study is not yet recruiting participants, but when it begins, it will focus on children aged 1 month to 16 years who have been diagnosed with Myasthenia Gravis based on medical evaluations and test results.

To participate, children must have a confirmed diagnosis of Myasthenia Gravis, and their caregivers must agree to be part of the study. However, children over the age of 16 or those with other neurological and muscle disorders will not be included. Participants can expect to undergo evaluations and tests as part of the study, which will help improve our understanding of this condition in children. This research is important as it aims to enhance treatment and care for young patients with Myasthenia Gravis.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All patients from 1 month to 16 years confirmed diagnosis of myasthenia gravis by neurological and laboratory data.
• • Care giver accept to participate in the study.
• Exclusion Criteria:
• • Failure to obtain informed consent. Other neurological and neuromuscular disorders. Age above 16 years.